| Clinical data | |
|---|---|
| Trade names | Panimycin, Tokocin |
| Other names | 3',4'-Dideoxykanamycin B |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| PDB ligand | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.047.316 |
| Chemical and physical data | |
| Formula | C18H37N5O8 |
| Molar mass | 451.521 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dibekacin (3',4'-dideoxykanamycin B) is anaminoglycosideantibiotic. It is a semisynthetic derivative ofkanamycin developed byHamao Umezawa and collaborators forMeiji Seika.[1][2]
It has been used in combination withsulbenicillin.[3]
This systemicantibiotic-related article is astub. You can help Wikipedia byexpanding it. |